• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型黏液穿透脂质体作为一种有潜力的口服药物传递系统:制备、体外特性鉴定和增强细胞摄取。

Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake.

机构信息

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

出版信息

Int J Nanomedicine. 2011;6:3151-62. doi: 10.2147/IJN.S25741. Epub 2011 Dec 2.

DOI:10.2147/IJN.S25741
PMID:22163166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3235033/
Abstract

BACKGROUND

The aim of this study was to investigate the intestinal mucus-penetrating properties and intestinal cellular uptake of two types of liposomes modified by Pluronic F127 (PF127).

METHODS

The two types of liposomes, ie, PF127-inlaid liposomes and PF127-adsorbed liposomes, were prepared by a thin-film hydration method followed by extrusion, in which coumarin 6 was loaded as a fluorescence marker. A modified Franz diffusion cell mounted with the intestinal mucus of rats was used to study the diffusion characteristics of the two types of PF127 liposomes. Cell uptake studies were conducted in Caco-2 cells and analyzed using confocal laser scanning microcopy as well as flow cytometry.

RESULTS

The diffusion efficiency of the two types of PF127-modified liposomes through intestinal rat mucus was 5-7-fold higher than that of unmodified liposomes. Compared with unmodified liposomes, PF127-inlaid liposomes showed significantly higher cellular uptake of courmarin 6. PF127-adsorbed liposomes showed a lower cellular uptake. Moreover, and interestingly, the two types of PF127-modified liposomes showed different cellular uptake mechanisms in Caco-2 cells.

CONCLUSION

PF127-inlaid liposomes with improved intestinal mucus-penetrating ability and enhanced cellular uptake might be a potential carrier candidate for oral drug delivery.

摘要

背景

本研究旨在研究两种经 Pluronic F127(PF127)修饰的脂质体的肠道黏液穿透特性和肠道细胞摄取特性。

方法

采用薄膜水化法制备 PF127 镶嵌脂质体和 PF127 吸附脂质体,其中香豆素 6 作为荧光标记物。使用改良的 Franz 扩散池,该扩散池带有大鼠肠黏液,研究两种类型的 PF127 脂质体的扩散特性。在 Caco-2 细胞中进行细胞摄取研究,并使用共聚焦激光扫描显微镜和流式细胞术进行分析。

结果

两种类型的 PF127 修饰的脂质体通过大鼠肠道黏液的扩散效率比未修饰的脂质体高 5-7 倍。与未修饰的脂质体相比,PF127 镶嵌脂质体对香豆素 6 的细胞摄取明显更高。PF127 吸附脂质体的细胞摄取较低。此外,有趣的是,两种类型的 PF127 修饰的脂质体在 Caco-2 细胞中表现出不同的细胞摄取机制。

结论

具有改善的肠道黏液穿透能力和增强的细胞摄取能力的 PF127 镶嵌脂质体可能是口服药物递送的潜在载体候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/a0ed1c59ce39/ijn-6-3151f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/95fc92b53824/ijn-6-3151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/13634ae177bc/ijn-6-3151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/83e589e0afe2/ijn-6-3151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/3c3649e1386a/ijn-6-3151f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/93ff3c522e8b/ijn-6-3151f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/a0ed1c59ce39/ijn-6-3151f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/95fc92b53824/ijn-6-3151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/13634ae177bc/ijn-6-3151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/83e589e0afe2/ijn-6-3151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/3c3649e1386a/ijn-6-3151f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/93ff3c522e8b/ijn-6-3151f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3235033/a0ed1c59ce39/ijn-6-3151f6.jpg

相似文献

1
Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake.新型黏液穿透脂质体作为一种有潜力的口服药物传递系统:制备、体外特性鉴定和增强细胞摄取。
Int J Nanomedicine. 2011;6:3151-62. doi: 10.2147/IJN.S25741. Epub 2011 Dec 2.
2
Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.泊洛沙姆 F127 修饰脂质体和壳聚糖修饰脂质体对环孢素 A 在大鼠体内黏液穿透和口服吸收的比较研究。
Int J Pharm. 2013 Jun 5;449(1-2):1-9. doi: 10.1016/j.ijpharm.2013.04.002. Epub 2013 Apr 11.
3
Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.黏液附着和穿透增强型紫杉醇脂质体口服递药系统
Int J Pharm. 2018 Feb 15;537(1-2):245-256. doi: 10.1016/j.ijpharm.2017.12.044. Epub 2017 Dec 27.
4
The modulation of the permeability and the cellular uptake of liposome by stable anchoring of lipid-conjugated pluronic on liposome.通过将脂质共轭型普朗尼克稳定锚定在脂质体上,调节脂质体的通透性和细胞摄取。
J Biomed Nanotechnol. 2014 Jan;10(1):100-8. doi: 10.1166/jbn.2014.1788.
5
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.口服胰岛素递送用核壳冠纳米脂质体后肠黏膜通透性。
Biomaterials. 2013 Dec;34(37):9678-87. doi: 10.1016/j.biomaterials.2013.08.048. Epub 2013 Sep 7.
6
Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration.泊洛沙姆 F127 修饰的含他克莫司-环糊精包合物的脂质体:提高溶解度、细胞摄取和肠道渗透。
J Pharm Pharmacol. 2013 Aug;65(8):1107-17. doi: 10.1111/jphp.12074. Epub 2013 May 16.
7
The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.用于增强口服药物递送的紫杉醇-胶束-脂质体杂化系统的构建与表征。
Colloids Surf B Biointerfaces. 2017 Dec 1;160:572-580. doi: 10.1016/j.colsurfb.2017.10.016. Epub 2017 Oct 5.
8
Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.基于十字花科植物蛋白的纳米颗粒与Caco-2细胞及Caco-2/HT29-MTX共培养物的相互作用。
Acta Biomater. 2017 Dec;64:249-258. doi: 10.1016/j.actbio.2017.10.017. Epub 2017 Oct 10.
9
PEGylated Nanoemulsions for Oral Delivery: Role of the Inner Core on the Final Fate of the Formulation.聚乙二醇化纳米乳液的口服给药:内核在制剂最终归宿中的作用。
Langmuir. 2017 May 2;33(17):4269-4279. doi: 10.1021/acs.langmuir.7b00351. Epub 2017 Apr 19.
10
Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome.口服穿透黏液的聚乙二醇化脂质体以改善药物吸收:一种黏附性脂质体的相互作用机制的差异。
Int J Pharm. 2021 Jan 25;593:120148. doi: 10.1016/j.ijpharm.2020.120148. Epub 2020 Dec 5.

引用本文的文献

1
Exploring peptide dendrimers for intestinal lymphatic targeting: formulation and evaluation of peptide dendrimer conjugated liposomes for enhancing the oral bioavailability of Asenapine maleate.探索用于肠道淋巴靶向的肽树状聚合物:肽树状聚合物缀合脂质体的配方和评价,以提高马来酸阿塞那平的口服生物利用度。
Sci Rep. 2024 Nov 15;14(1):28225. doi: 10.1038/s41598-024-79372-5.
2
Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis.脂质体:一种有效治疗类风湿关节炎的新兴策略。
Curr Rheumatol Rev. 2025;21(2):123-143. doi: 10.2174/0115733971284274240215064826.
3
Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy.

本文引用的文献

1
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.含甘氨胆酸钠的脂质体作为潜在的口服胰岛素传递系统:制备、体外特性分析及对酶降解的保护作用改善。
Int J Nanomedicine. 2011;6:1155-66. doi: 10.2147/IJN.S19917. Epub 2011 Jun 8.
2
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.含胆汁盐脂质体提高环孢素 A 的口服生物利用度。
Int J Nanomedicine. 2011;6:965-74. doi: 10.2147/IJN.S19259. Epub 2011 May 4.
3
Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers.
负载槲皮素的PF127修饰丝素蛋白纳米颗粒经肺部给药用于肺癌治疗,其可穿越黏液。
Asian J Pharm Sci. 2023 Jul;18(4):100833. doi: 10.1016/j.ajps.2023.100833. Epub 2023 Jul 28.
4
Development of Lipidic Nanoplatform for Intra-Oral Delivery of Chlorhexidine: Characterization, Biocompatibility, and Assessment of Depth of Penetration in Extracted Human Teeth.用于口腔内递送氯己定的脂质纳米平台的研发:特性、生物相容性及在拔除人牙中的渗透深度评估
Nanomaterials (Basel). 2022 Sep 27;12(19):3372. doi: 10.3390/nano12193372.
5
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.改善口服纳米给药系统在胃肠道中的滞留和药代动力学的黏液相互作用。
J Nanobiotechnology. 2022 Aug 6;20(1):362. doi: 10.1186/s12951-022-01539-x.
6
Liposomal -acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis.脂质体 - 酰基乙醇胺水解酸酰胺酶(NAAA)抑制剂F96作为结肠炎的一种新疗法。
RSC Adv. 2020 Sep 15;10(56):34197-34202. doi: 10.1039/d0ra05264g. eCollection 2020 Sep 10.
7
Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles.用于药物递送的聚合物/脂质体组装体的最新进展:从表面修饰到混合囊泡
Polymers (Basel). 2021 Mar 26;13(7):1027. doi: 10.3390/polym13071027.
8
Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease.藤黄脂素包封的pH敏感型可生物降解纳米颗粒:一种治疗炎症性肠病的新型治疗策略。
Polymers (Basel). 2021 Mar 11;13(6):862. doi: 10.3390/polym13060862.
9
Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity.精确制备的载有舒必利的纳米脂质体,改善了口服生物利用度和抗抑郁活性。
Int J Nanomedicine. 2021 Mar 9;16:2013-2044. doi: 10.2147/IJN.S296726. eCollection 2021.
10
Current approaches in lipid-based nanocarriers for oral drug delivery.当前用于口服药物递送的基于脂质的纳米载体方法。
Drug Deliv Transl Res. 2021 Apr;11(2):471-497. doi: 10.1007/s13346-021-00908-7. Epub 2021 Feb 2.
非离子表面活性剂泊洛沙姆 188 对难溶性药物经 Caco-2 细胞单层的被动渗透的影响。
Eur J Pharm Biopharm. 2011 Oct;79(2):416-22. doi: 10.1016/j.ejpb.2011.04.010. Epub 2011 Apr 28.
4
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.经 N-乙酰半胱氨酸处理的囊性纤维化痰液中具有黏膜惰性的纳米颗粒的快速转运。
Nanomedicine (Lond). 2011 Feb;6(2):365-75. doi: 10.2217/nnm.10.123.
5
Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus.完全由安全材料组成的可生物降解纳米颗粒,能迅速穿透人体黏液。
Angew Chem Int Ed Engl. 2011 Mar 7;50(11):2597-600. doi: 10.1002/anie.201006849. Epub 2011 Feb 18.
6
Topical and mucosal liposomes for vaccine delivery.用于疫苗传递的局部和黏膜脂质体。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):356-75. doi: 10.1002/wnan.131. Epub 2011 Feb 25.
7
Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.基于脂质的口服多颗粒制剂 - 优势、技术进步和工业应用。
Expert Opin Drug Deliv. 2011 Feb;8(2):207-24. doi: 10.1517/17425247.2011.547469. Epub 2011 Jan 6.
8
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.体外和体内评价 WGA-卡波姆修饰脂质体作为口服肽递药载体。
Eur J Pharm Biopharm. 2011 Feb;77(2):216-24. doi: 10.1016/j.ejpb.2010.12.008. Epub 2010 Dec 13.
9
Interaction between Pluronic F127 and dioctadecyldimethylammonium bromide (DODAB) vesicles studied by differential scanning calorimetry.通过差示扫描量热法研究 Pluronic F127 和二油酰基二甲基溴化铵(DODAB)囊泡之间的相互作用。
Langmuir. 2010 Dec 7;26(23):17852-7. doi: 10.1021/la102603a. Epub 2010 Nov 4.
10
Barrier properties of gastrointestinal mucus to nanoparticle transport.胃肠道黏液对纳米颗粒转运的屏障特性。
Macromol Biosci. 2010 Dec 8;10(12):1473-83. doi: 10.1002/mabi.201000137. Epub 2010 Sep 20.